openPR Logo
Press release

Non-Invasive Prenatal Testing Market : Lucrative Opportunities

02-06-2020 07:13 AM CET | Health & Medicine

Press release from: Transparency Market Research

Non-Invasive Prenatal Testing Market : Lucrative

Non-Invasive Prenatal Testing Market: Introduction

Transparency Market Research has published a new report titled 'Global Non-Invasive Prenatal Testing Market'. According to the report, the global non-invasive prenatal testing market was valued at approximately US$ 1.3 Bn in 2018. The global non-invasive prenatal testing market is expected to expand at a CAGR of 16.4% during the forecast period from 2019 to 2027.


Rise in prevalence of chronic conditions, such as cancer and diabetes, has increased the patient pool, followed by rise in demand for biologic drugs for treating various chronic conditions, resulting in boosting the growth of the Non-Invasive Prenatal Testing market.

Report Overview @

The market is anticipated to witness strong growth from 2019 to 2027. Increasing demand for early and non-invasive procedures is also considered as a major factor driving the NIPT market globally. For pregnant women at high risk of fetal chromosomal abnormalities (women aged 35 years and older, personal or family history of aneuploidy and positive result with conventional screening method), making a decision at early stage is very important, as a delay may lead to unnecessary pain and discomfort along with developmental issues with the fetus.

Rising demand for early screening is projected to trigger the demand for NIPTs globally, as most NIPTs available in the market can be recommended as early as 9 weeks to 10 weeks of gestation. Traditional invasive prenatal testing, such as amniocentesis and chronic villus sampling (CVS), are associated with the risk of miscarriage. On account of the fact that NIPTs completely eliminate the risk of miscarriage, they are being increasingly preferred by women over invasive prenatal testing.

Globally, the average age of first-time mothers is increasing, especially in developed countries such as U.S., U.K., France, Germany, Italy, and Japan. Financial stability, rising literacy rates, and social factors are key factors responsible for the advancing maternal age. The risk of fetal chromosomal aneuploidies is directly related to the rise in maternal age.

Request PDF Sample of Non-Invasive Prenatal Testing Market Report @

Increasing maternal age and advantages of NIPT over traditional invasive testing are some of the factors responsible for driving the market growth
Materni21 Test Type Segment to Dominate Global Market

Based on test type, the MaterniT21 segment accounted for major share of the global non-invasive prenatal testing market in 2018.

Dominance of the segment in the global market is attributable to strong brand reputation of MaterniT21 and acquisition of Sequenom by Labcorp.

In the U.S, Sequenom (which is presently a part of Labcorp) introduced MateriT21 in 2011, which was the first NIPT solution in the U.S. MaterniT21 is able to identify trisomies and expanded tests may also explain sex chromosomes disabilities and some microdeletions. Less percentage error is a significant advantage of MaterniT21. In addition to MaterniT21, the panorama segment held a notable share of the market, in terms of volume, in 2018.

Trisomy Tests to Witness High Adoption During Forecast Period

Based on application, the trisomy segment held a prominent share in 2018 in non-invasive prenatal testing market. The segment is likely to be highly lucrative during the forecast period.

According to the United Nations, the estimated rate of incidence of Down Syndrome ranges from 1 in 1,000 live births per year to 1 in 1,100 live births per year. Around 95% cases of Down Syndrome are nondisjunction cases, whereas translocation and mosaicism cases account for the rest of 5%.

Dominance of the trisomy segment is attributable to the increasing prevalence of Down Syndrome worldwide and high efficiency of NIPT for screening of Down Syndrome.

Buy Now "Non-Invasive Prenatal Testing Market" Research Report @<ype=S

Global Non-Invasive Prenatal Testing Market: Prominent Regions

North America held the largest share of the global Non-Invasive Prenatal Testing market in 2018. North America accounted for significant share of the global Non-Invasive Prenatal Testing market in 2018. The market in the region is likely to grow at a rapid pace during the forecast period.

The market in the region is driven by presence of key players, large number of research activities, and highly structured health care industry

Increase in investment by key players in North America and increasing maternal age are projected to propel the non-invasive prenatal testing market in North America

The U.S. is projected to dominate the non-invasive prenatal testing market in the region during the forecast period, owing to early adoption of technologies. The country is anticipated to be the most attractive market for non-invasive prenatal testing, with high attractiveness index.

Well-equipped hospitals, technological advancements, rise in research & development in non-invasive prenatal testing for new applications, and surge in demand for novel products and treatments are projected to ameliorate the non-invasive prenatal testing market in the U.S.

Global Non-Invasive Prenatal Testing Market: Key Players

Players are strengthening their product portfolio and are collaborating with other companies to secure and strengthen their positions in the non-invasive prenatal testing market. For instance, in July 2018, Berry Genetics partnered with 10X Genomics to upgrade non-invasive DNA prenatal testing. This collaboration was the first step for 10X Genomics to enter into the market in China.

In July 2016, Laboratory Corporation announced the acquisition of Sequenom for US$ 371 Mn, including debt. With this acquisition, Laboratory Corporation would strengthen its presence outside the U.S., in Europe and Asia Pacific, and enable it to provide top quality NIPT services.

Major players operating in the global Non-Invasive Prenatal Testing market include Berry Genetics, BGI, Laboratory Corporation of America Holdings, Agilent Technologies, Inc., Illumina, Inc, F. Hoffmann-La Roche Ltd, NATERA, INC., PerkinElmer Inc, Eurofins LifeCodexx AG, and IGENOMIX.

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Non-Invasive Prenatal Testing Market : Lucrative Opportunities here

News-ID: 1920935 • Views:

More Releases from Transparency Market Research

At a CAGR of 5.2%, Oral Solid Dosage Pharmaceutical Formulation Market is Projected to Reach USD 1.1 Billion by 2034 | TMR Research
At a CAGR of 5.2%, Oral Solid Dosage Pharmaceutical Formulation Market is Projec …
Oral solid dosage (OSD) forms are the most common and widely used pharmaceutical formulations, encompassing tablets, capsules, powders, and granules. These formulations are favored for their stability, ease of administration, and patient compliance. The global market for OSD pharmaceutical formulations is substantial, driven by advancements in drug delivery technologies, growing pharmaceutical industry, and increasing prevalence of chronic diseases requiring long-term medication. This article explores the current state and future prospects
Immersion Cooling Industry Set to Grow from USD 287.7 Million to USD 1.8 Billion by 2034
Immersion Cooling Industry Set to Grow from USD 287.7 Million to USD 1.8 Billion …
The global immersion cooling market (浸漬冷却市場) was valued at US$ 287.7 million in 2023. It is projected to advance at a compound annual growth rate (CAGR) of 17.9% from 2024 to 2034, reaching US$ 1.8 billion by the end of 2034. Download Sample Report Copy Here: Analyst Viewpoint The increasing investment in data center infrastructure is a significant driver of the immersion cooling market. The surge in internet usage and data
Advanced Wind Turbine Blade Materials Market to Reach USD 9.8 Billion by 2034 with 6.3% CAGR
Advanced Wind Turbine Blade Materials Market to Reach USD 9.8 Billion by 2034 wi …
The global advanced wind turbine blade materials market (첨단 풍력 터빈 블레이드 재료 시장) was valued at US$ 5.0 billion in 2023. It is estimated to grow at a compound annual growth rate (CAGR) of 6.3% from 2024 to 2034, reaching US$ 9.8 billion by the end of 2034. Download Sample Report Copy Here: Analyst Viewpoint The reduction in fossil fuel dependency is a major factor driving the development of the
Non-Muscle Invasive Bladder Cancer Market Size is Anticipated to Grow at a CAGR of 21.4% by 2034 | TMR Study
Non-Muscle Invasive Bladder Cancer Market Size is Anticipated to Grow at a CAGR …
Non-muscle invasive bladder cancer (NMIBC) represents a significant portion of bladder cancer cases, characterized by cancerous cells confined to the inner layers of the bladder wall. NMIBC includes stages Ta, T1, and carcinoma in situ (CIS). The management of NMIBC focuses on tumor removal, recurrence prevention, and progression to muscle-invasive stages. The global market for NMIBC treatments is expanding, driven by advancements in diagnostic techniques, emerging treatment modalities, and increasing

All 5 Releases

More Releases for Test

CAGR 8.1% Homecare Pregnancy Test Kits Market By Type of Test (Urine Test For H …
The Homecare Pregnancy Test Kits market report by Reports and Data provides an extensive overview of the vital elements of the Homecare Pregnancy Test Kits market and factors such as the drivers, restraints, latest trends, supervisory scenario, competitive landscape, technological advancements, and others. Further, it mentions the market shares associated with the market in terms of both value and volume along with the segmentation. Space-age industrial and digitalization tools are
Home Safety Test Kits Market, Home Safety Test Kits Market Trends, Home Safety T …
“Home Safety Test Kits Market” 2020-2025 Research Report is a professional and in-depth study on the current state of the market. Global Home Safety Test Kits market containing a complete view of the market size, business share, profit estimates, SWOT analysis and the regional landscape of the Industry. The report explains key challenges and future development prospects of the market. The Global Home Safety Test Kits analysis is provided for
Test Data Management (TDM) Market - test data profiling, test data planning, tes …
The report categorizes the global Test Data Management (TDM) market by top players/brands, region, type, end user, market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors. This report studies the global market size of Test Data Management (TDM) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption
Hearing Screening and Diagnostic Devices Market Demands with Major Tests: pure T …
New Market Research Reports Title "Hearing Screening And Diagnostic Devices Market 2018" Has Been Added to Crystal Market Research Report database. Hearing Screening and Diagnostic Devices - Competitive Insights: The leading players in the market are Gn Otometrics A/S, Otodynamics, Nashua Hearing Group, Siemens Healthineers, Natus Medical Incorporated, Interacoustics A/S, Neurosoft S.A, Accent Hearing Pty Ltd, MAICO Diagnostics GmbH and IntriCon Corporation. The major players in the market are profiled in detail
Women’s Health Diagnostic Test Market - By Application Ovarian Cancer Test, Br …
In 2017, Naugatuck Valley Women’s Health Specialists (NVWHS) decided to provide a free informational program for heart health with Boston Heart Diagnostics. Boston Heart diagnostics has anticipating treatment and diagnosis of cardiovascular diseases (CVD), which improves women’s heart health, as CVD is a leading disease in the U.S. This program is expected to create awareness of CVD related diseases among women and also help to improve lifestyle. Download The PDF Brochure:
Global RF Shielded Test Enclosures Market 2018 - Tescom, JRE Test, Anritsu, ARF …
Apex Market Reports, recently published a detailed market research study focused on the “RF Shielded Test Enclosures Market” across the global, regional and country level. The report provides 360° analysis of “RF Shielded Test Enclosures Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend